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Abstract
Background Post-traumatic seizures cause secondary brain
injury, contributing to morbidity and mortality after
traumatic brain injury. Seizure activity may be undetectable
if the patient is paralysed and ventilated.
Aims The effect of prophylactic anticonvulsant therapy on
the prevention of seizures after moderate to severe
traumatic brain injury was studied.
Methods A structured systematic literature review was
performed.
Results There may be a place for prophylactic anticonvul-
sants in the prophylaxis of early post-traumatic seizures.
Conclusion Furtherrandomisedcontrolledtrialsareneededto
firmly establish the benefits of prophylactic anticonvulsants.
Keywords Head injury.Seizure.Anticonvulsants.
Prophylaxis
Introduction
Trauma is an important cause of epilepsy. Post-traumatic
epilepsy is defined as a recurrent seizure disorder due to
traumatic brain injury. Post-traumatic epilepsy has become
an important clinical problem in many countries, as the
incidence of head injuries is steadily increasing, especially
from road traffic accidents [1]. Post-traumatic epilepsy has
been reported in 5–7% of all hospitalised patients with
traumatic brain injury [2].
Post-traumatic epilepsy can be divided into three groups:
immediate seizure, occurring within 24 h of injury; early
seizure, occurring within 7 days of injury; and late seizure,
occurring more than 7 days after injury. The incidence of each
following civilian head injury ranges from 1 to 4%, 4 to 25%
and 9 to 42%, respectively [3].
Children are reported to have greater risk of early post-
traumatic epilepsy as compared to adults after severe
traumatic brain injury. The reported incidence of early
post-traumatic epilepsy in children is 20–30% compared to
4–25%inadults.Theincidenceoflatepost-traumaticepilepsy
in children is 7–12% as compared to 9–13% in adults.
In early post-traumatic epilepsy the peak incidence usually
occurs within the initial 48 h of the causative head injury [4].
However, some seizures may escape clinical detection, and
hence may be unnoticed in intubated paralysed patients in
the absence of electroencephalography (EEG) monitoring.
The presence of convulsive status epilepticus is associated
with high mortality.
Effective prophylaxis of early post-traumatic seizures
reduces brain metabolic demands, thereby reducing intracranial
pressure and neurotransmitter release [5]. This in turn
minimises secondary brain injury. Furthermore, anticonvulsant
treatment can minimise cognitive and behavioural sequelae,
and may have effects on future employment and recreation.
There are currently no internationally agreed guidelines
available for the use of anticonvulsant prophylaxis for head
injuries.
Methods
A literature search (primary search) was performed using
the following databases:
& MEDLINE 1950 to 20 January 2010
& EMBASE 1974 to 20 January 2010
& CINAHL 1982 to 20 January 2010
Disclaimer The views expressed in this paper are those of the author(s)
and not those of the editors, editorial board or publisher.
A. A. Khan: A. Banerjee (*)
Chase Farm Hospital,
The Ridgeway,
Enfield EN2 8JL, UK
e-mail: libra19542003@yahoo.co.uk
Int J Emerg Med (2010) 3:187–191
DOI 10.1007/s12245-010-0180-1Additional sources included in the secondary search
strategy were:
1. The Cochrane Library
2. References from relevant articles
3. Web-based resources:
(a) http://www.bestbets.org/
(b) http://www.google.co.uk/
(c) http://www.uptodate.com/
(d) http://www.clinicaltrials.gov/
Two randomised controlled trials (RCTs) were identified
(Fig. 1), along with one meta-analysis (Fig. 2) and one
systematic review (Fig. 3).
All studies were of high quality (level 1 and Jadad score
4/5). Temkin et al. (1990) conducted a double-blind,
placebo-controlled trial at a level one trauma centre [6].
The primary end point of the study was the occurrence of
seizure. This was a good study with clearly stated outcome
and descriptions of randomisations, methods and double
blinding. Inclusion and exclusion criteria were stated. There
was no mention of power calculations; however, statistical
analyses were described. The study was limited by rather
small numbers in each group. Of the 586 patients assigned
to treatment, 404 met the eligibility requirements. Of the
eligible patients 208 were randomly assigned to the
phenytoin group and 196 to the placebo group.
In this trial, serum levels of phenytoin were indepen-
dently monitored and dosages were adjusted so that levels
were maintained. A significant reduction in the incidence of
early post-traumatic seizures in the treated group from 14.2
to 3.6% (p<0.001) was reported. The study presented
convincing evidence of the effectiveness of phenytoin in
preventing seizures in the first week after serious head
injury.
Young et al. (2004) reported a limited randomised
double-blinded, placebo-controlled trial investigating the
use of phenytoin for the prevention of early post-
traumatic seizures in children with moderate to severe
head injury [7]. It was observed that there is a low rate of
early post-traumatic seizures in children who had moder-
ate to severe head injury and received standard critical
care.
The review authors were unable to demonstrate a
significant difference in the rate of early post-traumatic
seizure between the phenytoin-treated and placebo-treated
groups because of the small sample size and because
phenytoin and benzodiazepines were used in the emergency
department and paediatric intensive care unit (ICU).
Another limitation of this study was many patients were
intubated and ventilated in the paediatric ICU and were not
monitored for subclinical post-traumatic seizures by using
continuous electroencephalograms.
Schierhout and Roberts reported a systematic review in
which they determined the effectiveness and safety of
prophylactic anticonvulsants in the management of acute head
injury [8]. Ten RCTs included patients with acute traumatic
brain injury of all grades of severity. The subjects were
assigned to either treatment or control groups on the basis of
randomisation allocation. The authors of this review excluded
the trials in which the intervention was started 8 weeks after
injury. Relative risk and 95% confidence intervals (CI) were
calculated for each trial on an intention to treat basis.
Heterogeneity between trials was tested using a χ
2 test.
Seven RCTs in the review were conducted to assess the
effect of anticonvulsants for the control of late seizures, and
three were RCTs for early seizures. In all of the studies the
three drugs used were phenytoin, carbamazepine and
phenobarbitone. The studies regarding the treatment/pre-
vention of early seizures used both carbamazepine and
phenytoin, whereas for the treatment of late seizures,
phenytoin and phenobarbitone were used.
The qualities of the trials analysed in this review ranged
from 1 to 5 on the Jadad scale. The pooled relative risks for
early seizures was 0.34 (95% CI: 0.21–0.54; p=0.000). No
beneficial effect of prophylactic anticonvulsant drugs was
evident for mortality. The review recommended that
anticonvulsant drugs may be used prophylactically in
high-risk patients for the first week after injury.
Temkin (2001) conducted a meta-analysis, the purpose
of which was to assess evidence concerning the effect of
anticonvulsant drugs for seizure prevention, and to contrast
their effectiveness for early and late seizures [3]. Inclusion
criteria were clearly stated. Forty-eight studies were
identified, and one was rejected; 14 studies with 15 drugs
evaluated the effect of recurrences of febrile convulsion and
13 studies with 15 drugs to prevent post-traumatic seizures.
It was concluded that phenytoin prevents early seizures
when administered within the first week after traumatic
brain injury. Carbamazepine was also determined to be
effective in the treatment/prevention of early seizures.
Lorazepam was determined to prevent alcohol-related
seizures, whereas verapamil was shown to have no role in
prevention of early seizures.
Discussion
Seizures occur frequently after severe head injury and are
often undiagnosed based on clinical examination only. The
occurrence of post-traumatic epilepsy is medically and
functionally an important complication of traumatic brain
injury.
Immediate and early seizures are likely to have a
different pathogenesis than late seizures. Closed head injury
may lead to diffuse axonal injury with shearing of axons,
188 Int J Emerg Med (2010) 3:187–191diffuse oedema and ischaemia leading to release of
excitatory amino acids, cytokines, bioactive lipids and
toxic mediators causing secondary cellular damage which
leads to immediate and early seizures [8].
Post-traumatic seizures correlate with the extent of brain
injury resulting from activation of a neurochemical cascade.
Lipid peroxides, intracellular calcium ions, glutamate and
free radicals are the major mediators for cell damage and
Author, 
date and 
country.
Methods. Number 
of paper 
included.
Search strategy.  Summary of results. 
Comments. 
Temkin, 
N.R 
2001 
USA 
Meta-analysis of 
published papers. 
The main aim was 
to asses the role of 
anti epileptic drug, 
or drug 
combination for 
preventing 
seizures associated 
with fever, 
alcohol, malaria, 
traumatic brain 
injury, and 
tumours. 
48 
Medline  
EMBASE  
Cochrane 
controlled trials. 
For traumatic 
brain injury, 
unpublished 
studies were 
identified through 
meetings and 
through informal 
communications. 
Phenytoin prevents 
provoked seizures 
first week after 
craniotomy and/or 
traumatic brain 
injury. 
Carbamazepine also 
effective in early 
traumatic brain 
injury. 
Phenobarbitone is 
effective in recurrent 
febrile seizures. 
No drug has been 
shown to be effective 
for provoked seizure 
after one week. 
Phenytoin is not anti-
epileptogenic,
but acts as a 
suppressor of 
seizures 
Inclusion criteria stated. 
Studies included clear questions being asked.  
Search strategy clearly stated.  
Sample size of all studies not stated. 
One trial was excluded from meta analysis, because 
the outcome was the number of periods with 
recurrences, and number of subjects with recurrences 
could not be determined. 
Relative risk mentioned. 
95% confidence interval calculated. 
Test for homogeneity for relative risk performed. 
Fisher’s exact test applied. 
Fig. 2 Summary of meta-analysis
Author, 
Year, 
Country. 
Study Design and 
Level of Evidence.
Patient Group 
and Medications 
Used. 
Outcome Measures   Key Outcomes  Critical Appraisal 
Temkin, 
N.R. 
1990 
USA 
Level 1 
trauma 
centre 
Randomised, double 
- blind placebo Trial 
Level 1b 
Jadad: 4 
Total 404:  
208 phenytoin  
196 placebo  
Seizures (early)  
Adverse reactions. 
Phenytoin group had a 
seizure rate of 3.6 ± 1.3 
percent. 
Placebo with 14.2 ± 
2.6percent. 
(P<0.001) 
Phenytoin treatment was 
associated with a 
decreased  risk of seizure 
in the first week. 
Inclusion and exclusion criteria stated. 
Randomised method not stated. 
Power calculation done. 
Cox regression models used for powerful analysis.  
Confidence interval measured. 
Limited study sample. 
Young, 
K.D 
2003 
USA 
Randomised, Double 
- blind, Placebo 
Controlled Trial.   
Multi centre. 
Level 1b. 
Jadad: 5 
102 Patients:  
42 given phenytoin  
56 given placebo. 
Seizures and Adverse 
reactions.  
Occurrence of clinical or 
electroencephalogram-
documented post-
traumatic seizures in 
48hours.  
Rate of early post-
traumatic seizure in 
children with moderate to 
severe was much lower. 
Inclusion and exclusion criteria stated.  Randomisation and 
method described in detail. Primary and secondary end-
points stated. 
Statistical methods :Fishers exact test rank, Wilcoxon rank 
sum test used. 
Type 1 error and type 2 identified. 
Study group was small. Study was incomplete. 
Serum level of phenytoin  was measured at the end of 
observation period on patients who were admitted 
EEG was not recorded to identify subclinical seizure. 
In addition to phenytoin ,benzodiazepines used. 
Fig. 1 Summary of randomised controlled trials
Int J Emerg Med (2010) 3:187–191 189death [10]. Patients with early seizures have a higher
incidence of intracranial pathology.
Penetrating injury causes direct neuronal damage and is
associated with post-traumatic epilepsy in 50% of cases.
Non-penetrating head injury, including contusions and
intracranial haemorrhages, is associated with post-
traumatic epilepsy in up to 30% of cases. This is partially
related to the toxic effect of haemoglobin breakdown
(ferrous sulphate) on the neuron.
Reported risk factors for seizures include Glasgow Coma
Scale score of less than 10/15, cortical contusions,
depressed skull fractures, early intracranial haematoma,
wounds with dural penetration, prolonged length of coma
(>24 h) and prolonged length of post-traumatic amnesia
(>24 h). The majority of early post-traumatic seizures occur
within the first 24 h.
Although genetic or predisposing factors have been
assumed to be significant in addition to the severity of
head injury in causation of post-traumatic epilepsy, the
attempts to demonstrate a genetic influence have been
inconclusive [7].
Risk factors for developing post-traumatic seizures
Glasgow Coma Scale (GCS) score <10
Cortical contusions
Depressed skull fracture
Subdural haematoma
Epidural haematoma
Intracerebral haematoma
Penetrating head wound
Factors which have been reported to lower the seizure
threshold include cerebral ischemia, head injury (closed and
penetrating), infection, metabolic disturbances, electrolyte
imbalance, hypoglycaemia, pH disturbance, drugs, and
hyperventilation. In case of severe head injury multiple
factors are involved.
It is known that injury to any part of the brain may result
in seizure, but the incidence is significantly greater when
damage is in the region adjacent to the temporal sulcus.
Loss or alteration in consciousness is the most reliable
clinical indicator of acute brain damage. When focal
damage is associated with prolonged loss of consciousness
the susceptibility to seizure is increased. It is known that the
epileptogenic process starts at the moment of trauma itself;
and therefore intervention should start soon after the
trauma, with the initial dose of prophylactic medication
being administered within 1 h [9].
Phenytoin, carbamazepine, sodium valproate and pheno-
barbitone have been demonstrated to be effective in the
treatment of generalised tonic-clonic or partial seizures.
Carbamazepine is an effective first-line agent for the
prevention of tonic-clonic and partial seizures; however,
carbamazepine is not available in the parenteral form,
thereby limiting its practical use in the emergency depart-
ment. Phenytoin has been shown to be effective in the
prevention of early/immediate seizure when administered
within the first week post-injury. It has also been shown to
suppress tonic-clonic and complex partial seizures. Phe-
nytoin is available in parenteral form and so is readily
available for use in the emergency department. The loading
dose of phenytoin is 18 mg/kg body weight.
Author, 
date and 
country.
Methods. Number 
of paper 
included.
Search strategy.  Summary of results. 
Comments. 
Schierhout, 
G.   
1998 
UK 
Systematic review 
Aim was to 
determine the 
effectiveness and 
safety of 
anticonvulsants in 
acute head injury 
10  RCT identified 
using MEDLINE 
1950-1996, 
EMBASE 1982-
1986, CINAHL 
1982-1996. 
Anti-epileptic drugs 
maybe used 
prophylactically in 
high risk patients 
within the week of 
injury. 
No beneficial effect 
of prophylactic 
antiepileptic drugs 
was evident for 
mortality. 
Heterogeneity between the trials was tested.  
Inclusion and exclusion mention, 
Relative risk and 95% confidence interval were 
calculated.  
Qualities of the RCT range given. 
Fig. 3 Summary of systematic review
190 Int J Emerg Med (2010) 3:187–191However, phenytoin is a negative inotrope and may
cause hypotension; it may also interfere with coagulation
function. The intramuscular route should not be used
because absorption is unreliable and leads to crystallisation
and abscess formation. When administered via the intrave-
nous route, phenytoin should be given slowly to reduce the
risk of cardiac arrhythmia and hypotension. Phenytoin may
also lead to toxic epidermal necrolysis, and the drug should
be stopped if a maculopapular erythematous rash is
induced.
None of the drug treatments reviewed appear to prevent
late seizures, regardless of the investigations and the type of
the injury. For the above reasons as a general rule
anticonvulsant drugs should only be used for prevention
of immediate and early seizure after moderate to severe
head injury.
Based on the available data, phenytoin can be justified as
a short-term treatment option to prevent seizures occurring
in the first week after trauma in high-risk patients, but not
in low-risk patients.
Conclusion
Based on a systematic review of RCTs, meta-analyses and
trial reports, it is concluded that prophylactic phenytoin
reduces the incidence of seizure in the first week after
injury but not thereafter. There is, therefore, potentially a
role for phenytoin administered via the intravenous route in
the suppression of early seizures in moderate to severe head
injury.
Treatment should be ideally started within 1 h of injury,
but is effective within the next 8 h. This allows for delays in
presentation, evaluation and transportation in individual
cases. The available data indicate that the rate of early post-
traumatic seizures in children is lower when compared to
adults; however, the data were limited in scope. Therefore,
there is a need for a larger multi-centre RCT to reliably
determine the best course of treatment for children.
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